Alzheimer's disease and amnestic mild cognitive impairment weaken connections within the default-mode network: a

David C Zhu1, Shantanu Majumdar, Igor O Korolev

  • 1Department of Radiology, Michigan State University, East Lansing, MI 48824, USA. zhuda@msu.edu

Insights

Alzheimer's disease (AD) and mild cognitive impairment (MCI) weaken brain connections in the default-mode network (DMN). This study used advanced imaging to reveal these structural and functional changes, offering insights into neurodegenerative disease progression.

Area of Science:

  • Neuroimaging
  • Neurodegenerative Diseases
  • Cognitive Science

Background:

  • Alzheimer's disease (AD) and amnestic mild cognitive impairment (aMCI) are characterized by progressive cognitive decline.
  • The default-mode network (DMN) is implicated in cognitive function and is known to be affected in neurodegenerative conditions.
  • Understanding the specific alterations within the DMN is crucial for early diagnosis and treatment development.

Purpose of the Study:

  • To investigate structural and functional changes in the DMN in patients with AD and aMCI using a multi-modal imaging approach.
  • To compare DMN connectivity in AD, aMCI, and normal controls (NC).
  • To explore the relationship between DMN alterations and disease progression.

Main Methods:

  • Multi-modal neuroimaging including resting-state functional MRI, diffusion-weighted MRI, volumetric MRI, and FDG-PET.
  • Functional and structural connectivity analyses of the DMN using the isthmus of the cingulate cortex (ICC) as a seed region.
  • Comparison of imaging data across three groups: probable AD, aMCI, and normal controls (NC).

Main Results:

  • Alzheimer's disease (AD) significantly weakens both structural and functional connections within the default-mode network (DMN).
  • These DMN alterations correlate with reduced metabolic activity and regional atrophy observed via FDG-PET and volumetric MRI.
  • A trend of progressive DMN connection weakening was observed from normal controls (NC) to aMCI and then to AD, though not statistically significant between aMCI and the other groups.

Conclusions:

  • The default-mode network (DMN) serves as a key indicator of brain changes in Alzheimer's disease (AD) and amnestic mild cognitive impairment (aMCI).
  • Multi-modal imaging reveals significant structural and functional disruptions in the DMN associated with AD.
  • The findings highlight the DMN's role in the progression of cognitive impairment and dementia.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...